Prevalence of the metabolic syndrome in a rural population in Ghana

BMC Endocrine Disorders

Rachel C Snow³  De-Anne Martey-Marbell²  Albert GB Amoah¹  Mawuli Gyakobo⁴ 

[1] Department of Medicine and Therapeutics; National Diabetes Management and Research Centre, University of Ghana Medical School, P. O. BOX 4236, Korle-Bu, Ghana;Consultant Family Physician and CEO Mission Clinic, P. O. Box AN 10545, Accra North, West Africa, Ghana;Department of Health Behaviour and Health Education, University of Michigan School of Public Health, 1415 Washington Heights 3814 SPH I, Ann Arbor, Michigan, 48109, USA;Ghana-Michigan Charter, C/O Office of the Provost, College of Health Sciences, University of Ghana, P. O. Box KB 52, Korle-Bu, Ghana

关键词: IDF;    ATPIII;    Determinants;    Rural Ghana;    Metabolic syndrome;   

Others  :  1086118
DOI  :  10.1186/1472-6823-12-25

 received in 2012-06-06, accepted in 2012-10-15,  发布年份 2012

【 摘 要 】

Background

The Metabolic syndrome (MS) which is a constellation of cardiometabolic risk factors including dyslipidaemia, hypertension, hyperglycaemia, central obesity, and endothelial dysfunction was hitherto relatively uncommon among Africans south of the Sahara. This study seeks to determine the prevalence of MS, its components and risk factors among a rural population in Ghana based on two popular international algorithms.

Methods

This was a cross-sectional survey of a rural population in Ghana conducted between November and December, 2007. Two hundred and twenty-eight (228) settler farmers, families and staff associated with the GOPDC Ltd, between the ages of 35 and 64 years, were randomly selected for the study; pregnant women were excluded. The prevalence of MS was estimated using the IDF and ATPIII criteria.

Results

The final subject pool included 102 males, and 104 females. The mean age of all subjects was 44.4 ± 6.9 years. The overall prevalence of MS by the IDF and ATPIII criteria were 35.9% and 15.0%, respectively, but there was an alarming female preponderance by both criteria {IDF: males = 15.7%, females =55.8%; ATPIII: males = 5.9%,females = 24.0%; sex differences p<0.001 for both criteria}. The most important determinants for IDF-defined MSwere central obesity (55.3%), low High Density Lipoprotein (42.7%) and high Blood Pressure (39.5%).

Conclusion

The triad of central obesity, high blood pressure and low HDL were most responsible for the syndrome in this rural population.

【 授权许可】

   
2012 Gyakobo et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Onyegbutulem HC, Pi HO, Reimann M, Li J, Bornstein SR, Schwarz PE: Metabolic syndrome in Africa: an emerging perspective. Horm Metab Res 2009, 41(2):75-78.
• [2]Azizi F, Salehi P, Etemadi A, Zahedi-Asl S: Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003, 61(1):29-37.
• [3]Day C: Metabolic syndrome, or What you will: definitions and epidemiology. Diab Vasc Dis Res 2007, 4(1):32-38.
• [4]Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(7):539-553.
• [5]Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al.: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112(17):2735-2752.
• [6]Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AO: Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study. Metab Syndr Relat Disord 2009, 7(3):221-229.
• [7]Wang W, Luo Y, Liu Y, Cui C, Wu L, Wang Y, et al.: Prevalence of metabolic syndrome and optimal waist circumference cut-off points for adults in Beijing. Diabetes Res Clin Pract 2010,  : . in press
• [8]Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005, 28(11):2745-2749.
• [9]Balkau B, Charles MA: Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999, 16(5):442-443.
• [10]Alberti KG, Zimmet P, Shaw J: The metabolic syndrome–a new worldwide definition. Lancet 2005, 366(9491):1059-1062.
• [11]Zabetian A, Hadaegh F, Azizi F: Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract 2007, 77(2):251-257.
• [12]Ford ES, Giles WH: A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003, 26(3):575-581.
• [13]Can AS, Bersot TP: Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study. BMC Publ Health 2007, 7:353. BioMed Central Full Text
• [14]Ko GTC, Cockram CS, Chow CC, Yeung VTF, Chan WB, So WY, et al.: Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese. Diabetes Res Clin Pr 2006, 73(1):58-64.
• [15]Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287(3):356-359.
• [16]Adegoke OA, Adedoyin RA, Balogun MO, Adebayo RA, Bisiriyu LA, Salawu AA: Prevalence of metabolic syndrome in a rural community in Nigeria. Metab Syndr Relat Disord 2010, 8(1):59-62.
• [17]Fezeu L, Balkau B, Kengne AP, Sobngwi E, Mbanya JC: Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis 2007, 193(1):70-76.
• [18]Oladapo OO, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase AO: A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey. Cardiovasc J Afr 2010, 21(1):26-31.
• [19]Alvarez Leon EE, Ribas Barba L, Serra Majem L: Prevalence of the metabolic syndrome in the population of Canary Islands, Spain. Med Clin (Barc) 2003, 120(5):172-174.
• [20]Athyros VG, Bouloukos VI, Pehlivanidis AN, Papageorgiou AA, Dionysopoulou SG, Symeonidis AN, et al.: The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study. Diabetes Obes Metab 2005, 7(4):397-405.
• [21]Athyros VG, Ganotakis ES, Bathianaki M, Monedas I, Goudevenos IA, Papageorgiou AA, et al.: Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study. Hellenic J Cardiol 2005, 46(6):380-386.
• [22]Boronat M, Chirino R, Varillas VF, Saavedra P, Marrero D, Fabregas M, et al.: Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals. Diabet Med 2005, 22(12):1751-1756.
• [23]Calbo Mayo JM, de Terrancle Juan I, Fernandez Jimenez P, Rodriguez Martin MJ, Martinez Diaz V, Santisteban Lopez Y, et al.: Prevalence of metabolic syndrome in the province of Albacete (Spain). Rev Clin Esp 2007, 207(2):64-68.
• [24]Gundogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, et al.: Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Metab Syndr Relat Disord 2009, 7(5):427-434.
• [25]Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA: Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Publ Health 2007, 7:220. BioMed Central Full Text
• [26]Sidorenkov O, Nilssen O, Brenn T, Martiushov S, Arkhipovsky VL, Grjibovski AM: Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study. BMC Publ Health 2010, 10:23. BioMed Central Full Text
• [27]Bo S, Ciccone G, Pearce N, Merletti F, Gentile L, Cassader M, et al.: Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects. Diabetes Res Clin Pract 2007, 75(3):362-365.
• [28]Hollman G, Kristenson M: The prevalence of the metabolic syndrome and its risk factors in a middle-aged Swedish population–mainly a function of overweight? Eur J Cardiovasc Nurs 2008, 7(1):21-26.
• [29]Lee CM, Huxley RR, Woodward M, Zimmet P, Shaw J, Cho NH, et al.: The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region. Diabetes Res Clin Pract 2008, 81(3):377-380.
• [30]Csaszar A, Kekes E, Abel T, Papp R, Kiss I, Balogh S: Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population. Blood Press 2006, 15(2):101-106.
• [31]Choi KM, Kim SM, Kim YE, Choi DS, Baik SH, Lee J: Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metabolism 2007, 56(4):552-558.
• [32]Carlsson AC, Wandell PE, Halldin M, de Faire U, Hellenius ML: Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women. Metab Syndr Relat Disord 2009, 7(3):231-241.
• [33]Alegria E, Cordero A, Laclaustra M, Grima A, Leon M, Casasnovas JA, et al.: Prevalence of metabolic syndrome in the Spanish working population: MESYAS registry. Rev Esp Cardiol 2005, 58(7):797-806.
• [34]Ko GT, Cockram CS, Chow CC, Yeung VT, Chan WB, So WY, et al.: Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese. Diabetes Res Clin Pract 2006, 73(1):58-64.